Rx Product News Profile: A Closer Look at New FDA Actions: Eurand's Zenpep
April 15th 2010Eurand Pharmaceuticals' Zenpep (pancrelipase) Delayed-Release Capsules have been approved by the FDA for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.
Drug Interactions with Tyrosine Kinase Inhibitors
April 15th 2010Tyrosine kinase inhibitors (TKIs) are indicated for the treatment of a variety of malignancies due to their ability to interfere with cell communication and growth. Interactions that affect TKI metabolism are discussed.
Specialty Pharmaceuticals: Treatment of Asthma with Biologic Therapy and MTM
April 15th 2010Patients with asthma have many options for treatment, including the biologic omalizumab (Xolair). Pharmacists who utilize a properly executed medication therapy management program will promote increased adherence to treatment.
Good and Bad News in Health Care Reform for Patients
April 14th 2010Health care reform has both good and bad news for patients. Americans will receive health care coverage and seniors no longer have to worry about falling into the Medicare "doughnut hole," but affordable biogenerics will not be available for decades.
The Impact of Stress on Health: Learning to Cope
April 14th 2010Stress can have serious health implications, increasing the risk of cardiovascular disease and exacerbating medical conditions such as asthma, diabetes, and hypertension. Stress is unavoidable, but learning to manage it effectively is critical.